Categorizing immune responders with fusion metrics and simulation for association to survival & progression free survival with immune response in HLA-A2+ patients with GBM from a phase 2 trial of dendritic cell (DC) immunotherapy (ICT-107).

Authors
Publication date
1 November 2016
Publisher
NSUWorks

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    NSU Works

    redirect
    oaioai:nsuworks.nova.edu:cnso_mat...
    Last time updated on 09/07/2019